Received Jun 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | LA |
A rash looking like chicken pox; This non-serious case was reported by a consumer and described the occurrence of varicella-like rash in a 85-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose of Shingrix on an unknown date). Concomitant products included atorvastatin calcium (Atorvastatin). On 12-JUN-2025, the patient received the 2nd dose of Shingrix (left arm). On 13-JUN-2025, 1 days after receiving Shingrix, the patient experienced varicella-like rash (Verbatim: A rash looking like chicken pox). The outcome of the varicella-like rash was resolving. It was unknown if the reporter considered the varicella-like rash to be related to Shingrix. It was unknown if the company considered the varicella-like rash to be related to Shingrix. Additional Information: GSK Receipt Date: 20-JUN-2025 The patient had taken subsequent dose of Shingrix on 12 Jun 2025. The reporter called patient received Shingrix vaccine on 12 Jun 2025 and had a rash on 13 Jun 2025. There was nothing that reporter would like to share about the primary disease. There was nothing that reporter would like to share about a complicating disease. There was nothing that reporter would like to provide any additional information about this report.
ATORVASTATIN